CRISPR
Crispr Therapeutics: Market Misunderstanding Is Your Buying Opportunity (Upgrade)
How can CRISPR edit out antimicrobial-resistance?
‘ChatGPT for CRISPR’ creates new gene-editing tools
Moderna ends collaboration with CRISPR company Metagenomi, parts ways with gene editing chief
Invest In A Revolutionary Gene Therapy With CRISPR Therapeutics
CRISPR is promising to tackle antimicrobial resistance, but bacteria can fight back
Buy Rating on Crispr Therapeutics: Anticipated Clinical Catalysts and Undervalued Autoimmune Prospects
Generative AI arrives in the gene editing world of CRISPR
CRISPR Therapeutics Stock (NASDAQ:CRSP) Pushes Lower, But Fundamentals Are Intact
Genetic Engineering
CRISPR-Crafted Cuisine: How Genetic Engineering Is Changing What We Eat
Genetic engineering was meant to save chestnut trees. Then there was a mistake.
US FDA clarifies it has full jurisdiction over GE animals, including fish
An Introduction to Genetic Engineering
Genetic engineering (Ge) – not the glow in the dark stuff…
RNA editing using CRISPRs shows promise for genetic disease treatment
Current uses of genetic engineering
Book Review – As Gods: A Moral History Of The Genetic Age By Matthew Cobb
An Introduction to Genetic Engineering
genetic engineering
Gene Editing
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire
Moderna exits gene editing deal worth up to $3B biobucks, leaving Metagenomi in the spotlight
Moderna ends collaboration with CRISPR company Metagenomi, parts ways with gene editing chief
Scientists identify ‘degrees of Kevin Bacon’ gene
‘ChatGPT for CRISPR’ creates new gene-editing tools
Moderna Walks Away from Potential $3B Gene Editing Deal with Metagenomi
Generative AI arrives in the gene editing world of CRISPR
Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health
Moderna ends gene editing alliance with Metagenomi
CRISPR Therapy
Invest In A Revolutionary Gene Therapy With CRISPR Therapeutics
Phase 3 Data Show Exa-Cel Prevents Vaso-Occlusive Crises for At Least 1 Year in SCD
Peninsula biotech co-founded by Jennifer Doudna lands CRISPR gene-editing pact with Regeneron
Peter Marks
Denmark’s SNIPR Biome secures $5.48M funding from CARB-X for clinical trial of CRISPR therapy in cancer patients
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
Generative AI arrives in the gene editing world of CRISPR
Regeneron, Mammoth Launch In Vivo CRISPR Gene Editing Collaboration
CRISPR Therapeutics Stock (NASDAQ:CRSP) Pushes Lower, But Fundamentals Are Intact
Profluent combines LLMs and CRISPR for open-source AI gene editing project
DNA
DNA helps investigators ID murder victim in 1989 Western Mass. cold case
DNA identifies child found in duffle bag as missing Philadelphia 4-year-old Damari Carter, police say
Man Does DNA Test, Not Prepared For What Comes Back 'Unusually High'
'Part of the DNA of the city': Council's Reggie Harris on Connected Communities rezoning
DNA Help Solve Identity of Jane Doe Found 30 Years Ago in Coachella, But Case Still Remains a Mystery
Terrence Shannon Jr.’s attorneys file motion to exclude state’s DNA testing in criminal case
MyHeritage DNA vs. Ancestry DNA: How They Compare
'Sexually violent predator' arrested for 1984 Everett woman's murder after DNA cracks case
FBI confirms new leads connected to DNA evidence and cellphone data in disturbing killings of elderly couple on Lake Oconee
DNA Sequencing
DNA sequencing reveals cause of rare neurological disorder
DNA sequencing firm PacBio to lay off workers and shutter San Diego office
Nanopore DNA Sequencing: A Powerful Tool for Genetic Analysis
What Does DNA Stand For, and How Does It Work?
Through DNA Sequencing, Experts Discover Surprising Truths About Vikings
DNA Says You're Related to an Ancient Famous Person. That Means Little
Mother-and-baby-home investigation to include DNA profiling using genetic material from maternal line
Share DNA With A Medieval Person? Here's What A Genetic Match Means
PacBio plots budget cuts after DNA sequencing revenue shortfalls